|
1
|
Fan L, Strasser-Weippl K, Li J-J, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
3
|
Ellis LM and Fidler IJ: Angiogenesis and
Metastasis. Eur J Cancer. 32A:2451–2460. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bikfalvi A: Significance of angiogenesis
in tumour progression and metastasis. Eur J Cancer. 31A:1101–1104.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fox SB: Tumor angiogenesis and prognosis.
Histopathology. 30:294–301. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weidner NSJ, Welch WR and Folkman J: Tumor
angiogenesis and metastasis - correlation in invasive breast
carcinoma. N Engl J Med. 324:81991. View Article : Google Scholar
|
|
7
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang C and Yang Q: Astrocyte elevated
gene-1 and breast cancer (Review). Oncol Lett. 2:399–405.
2011.PubMed/NCBI
|
|
10
|
Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C,
Moran MS, Shao C and Yang Q: Metadherin enhances the invasiveness
of breast cancer cells by inducing epithelial to mesenchymal
transition. Cancer Sci. 102:1151–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao Y, Kong X, Li X, Yan S, Yuan C, Hu W
and Yang Q: Metadherin mediates lipopolysaccharide-induced
migration and invasion of breast cancer cells. PLoS One.
6:e293632011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu C, Kong X, Wang H, et al: MTDH mediates
estrogen-independent growth and tamoxifen resistance by
down-regulating PTEN in MCF-7 breast cancer cells. Cell Physiol
Biochem. 33:1557–1567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang N, Wang X, Huo Q, Li X, Wang H,
Schneider P, Hu G and Yang Q: The oncogene metadherin modulates the
apoptotic pathway based on the tumor necrosis factor superfamily
member TRAIL (tumor necrosis factor-related apoptosis-inducing
ligand) in breast cancer. J Biol Chem. 288:9396–9407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Zhang N, Song LB, et al: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoo BK, Emdad L, Su ZZ, Villanueva A,
Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet
JM, et al: Astrocyte elevated gene-1 regulates hepatocellular
carcinoma development and progression. J Clin Invest. 119:465–477.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Su Z, Li G, et al: Increased
expression of metadherin protein predicts worse disease-free and
overall survival in laryngeal squamous cell carcinoma. Int J
Cancer. 133:671–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou J, Li J, Wang Z, Yin C and Zhang W:
Metadherin is a novel prognostic marker for bladder cancer
progression and overall patient survival. Asia Pac J Clin Oncol.
8:e42–e48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song L, Li W, Zhang H, Liao W, Dai T, Yu
C, Ding X, Zhang L and Li J: Over-expression of AEG-1 significantly
associates with tumour aggressiveness and poor prognosis in human
non-small cell lung cancer. J Pathol. 219:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tokunaga E, Nakashima Y, Yamashita N,
Hisamatsu Y, Okada S, Akiyoshi S, Aishima S, Kitao H, Morita M and
Maehara Y: Overexpression of metadherin/MTDH is associated with an
aggressive phenotype and a poor prognosis in invasive breast
cancer. Breast Cancer. 21:341–349. 2014. View Article : Google Scholar
|
|
20
|
Kong X, Moran MS, Zhao Y and Yang Q:
Inhibition of metadherin sensitizes breast cancer cells to AZD6244.
Cancer Biol Ther. 13:43–49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kikuno N, Shiina H, Urakami S, Kawamoto K,
Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M, et al:
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng X, Brachova P, Yang S, Xiong Z, Zhang
Y, Thiel KW and Leslie KK: Knockdown of MTDH sensitizes endometrial
cancer cells to cell death induction by death receptor ligand TRAIL
and HDAC inhibitor LBH589 co-treatment. PLoS One. 6:e209202011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu G, Chong RA, Yang Q, Wei Y, Blanco MA,
Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22
genomic gain promotes chemoresistance and metastasis of
poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009.
View Article : Google Scholar :
|
|
24
|
Fang JH, Zhou HC, Zeng C, Yang J, Liu Y,
Huang X, Zhang JP, Guan XY and Zhuang SM: MicroRNA-29b suppresses
tumor angiogenesis, invasion, and metastasis by regulating matrix
metalloproteinase 2 expression. Hepatology. 54:1729–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Zhang N, Huo Q and Yang Q:
Anti-angiogenic and antitumor activities of Huaier aqueous extract.
Oncol Rep. 28:1167–1175. 2012.PubMed/NCBI
|
|
26
|
Su P, Zhang Q and Yang Q:
Immunohistochemical analysis of Metadherin in proliferative and
cancerous breast tissue. Diagn Pathol. 5:382010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu J, Li X, Kong X, Moran MS, Su P,
Haffty BG and Yang Q: Testin is a tumor suppressor and prognostic
marker in breast cancer. Cancer Sci. 103:2092–2101. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Ach RA and Curry B: Direct and
sensitive miRNA profiling from low-input total RNA. RNA.
13:151–159. 2007. View Article : Google Scholar :
|
|
29
|
Du J, Xu R, Hu Z, Tian Y and YZ: PI3K and
ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α
expression in MCF-7 breast cancer cells. PloS One. 6:e252132011.
View Article : Google Scholar
|
|
30
|
Liu L, Cao Y, Chen C, Zhang X, McNabola A,
Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the
RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor
cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer
Res. 66:11851–11858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shan B, Li W, Yang S-Y and Li Z-R:
Estrogen up-regulates MMP2/9 expression in endometrial epithelial
cell via VEGF-ERK1/2 pathway. Asian Pac J Trop Med. 6:826–830.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu LZ, Li C, Chen Q, Jing Y, Carpenter R,
Jiang Y, Kung HF, Lai L and Jiang BH: MiR-21 induced angiogenesis
through AKT and ERK activation and HIF-1α expression. PLoS One.
6:e191392011. View Article : Google Scholar
|
|
34
|
Shapira I, Lee A, Vora R and Budman DR:
P53 mutations in triple negative breast cancer upregulate endosomal
recycling of epidermal growth factor receptor (EGFR) increasing its
oncogenic potency. Crit Rev Oncol Hematol. 88:284–292. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma J, Xue Y, Cui W, Li Y, Zhao Q, Ye W,
Zheng J, Cheng Y, Ma Y, Li S, et al: Ras homolog gene family,
member A promotes p53 degradation and vascular endothelial growth
factor-dependent angiogenesis through an interaction with murine
double minute 2 under hypoxic conditions. Cancer. 118:4105–4116.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Kong X, Wang Y and Yang Q: 53BP1 is
a novel regulator of angiogenesis in breast cancer. Cancer Sci.
104:1420–1426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li C, Li R, Song H, Wang D, Feng T, Yu X,
Zhao Y, Liu J, Yu X, Wang Y, et al: Significance of AEG-1
expression in correlation with VEGF, microvessel density and
clinicopathological characteristics in triple-negative breast
cancer. J Surg Oncol. 103:184–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bartholomeusz C, Gonzalez-Angulo AM, Liu
P, Hayashi N, Lluch A, Ferrer-Lozano J and Hortobágyi GN: High ERK
protein expression levels correlate with shorter survival in
triple-negative breast cancer patients. Oncologist. 17:766–774.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chetram MA and Hinton CV: PTEN regulation
of ERK1/2 signaling in cancer. J Recept Signal Transduct Res.
32:190–195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Anand S and Cheresh DA: Emerging role of
micro-RNAs in the regulation of angiogenesis. Genes Cancer.
2:1134–1138. 2011. View Article : Google Scholar
|
|
42
|
Yamada N, Tsujimura N, Kumazaki M,
Shinohara H, Taniguchi K, Nakagawa Y, Naoe T and Akao Y: Colorectal
cancer cell-derived microvesicles containing microRNA-1246 promote
angiogenesis by activating Smad 1/5/8 signaling elicited by PML
down-regulation in endothelial cells. Biochim Biophys Acta.
1839:1256–1272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang W, Ren F, Wu Q, Jiang D, Li H and Shi
H: MicroRNA-497 suppresses angiogenesis by targeting vascular
endothelial growth factor A through the PI3K/AKT and MAPK/ERK
pathways in ovarian cancer. Oncol Rep. 32:2127–2133.
2014.PubMed/NCBI
|
|
44
|
Zheng Y, Li S and Ding Y: The role of
miR-18a in gastric cancer angiogenesis. Hepatogastroenterology.
60:52013.
|
|
45
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar
|
|
46
|
Han M, Liu M and Wang Y: Antagonism of
miR-21 reverses epithelial-mesenchymal transition and cancer stem
cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
PLoS One. 7:112012.
|
|
47
|
Zhao D, Tu Y, Wan L, Bu L, Huang T, Sun X,
Wang K and Shen B: In vivo monitoring of angiogenesis inhibition
via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer
model using bioluminescent imaging. PLoS One. 8:e714722013.
View Article : Google Scholar : PubMed/NCBI
|
